What does Applied Biosciences Corp. do?

Applied Biosciences Corp. (APPB) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is APPB's market cap?

Applied Biosciences Corp. (APPB) has a market capitalization of approximately $2,200, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does APPB pay a dividend?

No — Applied Biosciences Corp. (APPB) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Applied Biosciences Corp. (APPB) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

APPB

Applied Biosciences Corp.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$2.20K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.99%CAGR −84.17%

Select date range

FromTo

Sep 10, 2003Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

APPB does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$859.86K

Net Income−$2.79M

Net Margin−324.1%

Operating Cash Flow−$933.90K

Capital Expenditures$1.56K

Free Cash Flow−$935.46K

Return on Equity−1,215.4%

Return on Invested Capital−47.3%

Net Debt$893.25K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for APPB and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how APPB's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for APPB and 80,000+ other tickers.

About Applied Biosciences Corp.

Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.

CEO: Christopher Michael Bridges
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 25
Website: www.appliedbiocorp.com

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About APPB

What does Applied Biosciences Corp. do?: Applied Biosciences Corp. (APPB) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is APPB's market cap?: Applied Biosciences Corp. (APPB) has a market capitalization of approximately $2,200, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does APPB pay a dividend?: No — Applied Biosciences Corp. (APPB) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is APPB profitable?: Applied Biosciences Corp. (APPB) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.